| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 6 | 14 | 14 | 13 | 23 | 30 | 37 | 23 | 30 | 41 | 34 | 35 |
| Expenses | 5 | 12 | 11 | 11 | 22 | 28 | 34 | 21 | 29 | 39 | 33 | 31 |
| EBITDA | 1 | 1 | 3 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 4 |
| Operating Profit % | 13 % | 7 % | 19 % | 8 % | 4 % | 6 % | 4 % | 6 % | 4 % | 2 % | 3 % | 2 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 3 |
| Tax | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
| Net Profit | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
| EPS in ₹ | 0.36 | 0.48 | 1.10 | 0.29 | 0.30 | 0.74 | 0.77 | 0.44 | 0.34 | 0.44 | 0.34 | 1.70 |
Biofil Chemicals
Biofil Chemicals
39.71
+0.33
(0.84%)
Key Fundamentals
Market Cap
64.10 Cr
EPS
0.34
PE Ratio
22.84
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
75.50
52 Week Low
39.01
PB Ratio
3.40
Debt to Equity
0.02
Sector
Pharmaceuticals Actual
Company News
View All News
Biofil Chemicals and Pharmaceuticals Limited received shareholder approval through postal ballot for the sale, transfer, or disposal of leasehold rights for a vacant portion of industrial land measuring 80,156 square meters at Pithampur, Madhya Pradesh. The special resolution was passed with 99.93% votes in favor, with 8,974,224 votes supporting and 6,503 votes against. The e-voting process was conducted from August 15 to September 13, 2025, with L.N. Joshi serving as scrutinizer. Out of 25,845 total shareholders, postal ballot notices were sent to 23,017 members via email. The resolution allows the company to dispose of leasehold rights for the vacant industrial land located at Plot No. 8, Sector-3, Kheda Industrial Estate, Pithampur, District Dhar, Madhya Pradesh.
Biofil Chemicals & Pharmaceuticals Limited appointed Mr. Smitesh Shah as an Additional Director in the category of Promoter Non-Executive Non Independent Director, effective August 23rd, 2025. The appointment is subject to shareholder approval at the upcoming 40th Annual General Meeting. Shah, aged 65, holds a B.Sc degree and has 45 years of experience in the pharmaceuticals industry. He is the uncle of Ketan Shah, the company's Chairman and Managing Director. The appointment was made upon recommendations of the Nomination and Remuneration Committee. Shah will hold office until the ensuing AGM or within three months from the appointment date, whichever is earlier. He currently holds directorships in 6 other companies.
Biofil Chemicals Reports Q1 FY26 Financial Results; Multiple Companies Announce Quarterly EarningsAug 14, 2025
Biofil Chemicals and Pharmaceuticals Limited published its unaudited financial results for the quarter ended June 30, 2025, with board approval on August 12, 2025. The results were published in newspapers on August 14, 2025, including Free Press Mumbai & Indore and Choutha Sansar. Several other companies also reported quarterly results: Deutsche Investments India Private Limited, Ironwood Education Limited announced its 2nd Annual General Meeting scheduled for September via video conferencing, Empire Industries Limited reported total income from operations and various profit/loss figures, Grand Foundry Limited showed a net loss of Rs 14.69 lakhs for the quarter, and Daikaffil Chemicals India Limited published its quarterly financial results. The companies' results include various financial metrics such as total income from operations, net profit/loss figures, equity share capital, and earnings per share data.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,679.10 | #1 3,98,049.70 | 38.75 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 61.71 | |
6,621.50 | 1,75,222.50 | 76.19 | 9,712.00 | 18.67 | 2,191 | 26.74 | 72.60 | |
1,577.60 | 1,26,768.90 | 23.67 | 28,409.50 | 7.12 | 5,291 | 9.88 | 60.63 | |
3,584.30 | 1,19,599.80 | 60.49 | 11,539.40 | 6.99 | 1,911 | 19.91 | 53.74 | |
1,255.90 | 1,03,508.80 | #1 18.25 | 33,741.20 | 16.73 | 5,725 | 1.26 | 48.97 | |
2,476.60 | 1,01,344.60 | 53.48 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 47.04 | |
987.65 | 99,073.80 | 21.09 | 23,511.00 | 18.55 | 4,615 | 2.60 | 45.37 | |
1,940.00 | 89,121.90 | 23.79 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.82 | |
5,581.50 | 66,047.70 | 28.61 | 13,458.30 | 3.70 | 2,216 | 21.39 | 63.11 | |
1,101.00 | 64,254.10 | 19.04 | 32,345.60 | 9.43 | 3,484 | -10.24 | 50.87 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-16.79 %
Net Income Growth
-14.29 %
Cash Flow Change
-180.33 %
ROE
-23.85 %
ROCE
-17.38 %
EBITDA Margin (Avg.)
6.21 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 14 | 24 | 22 | 24 | 24 | 42 | 33 | 19 | 31 | 47 | 51 |
| Fixed Assets | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 | 9 | 8 |
| Current Assets | 5 | 15 | 13 | 15 | 14 | 32 | 24 | 9 | 22 | 38 | 43 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 5 | 15 | 13 | 15 | 14 | 32 | 24 | 9 | 22 | 39 | 43 |
| Total Liabilities | 14 | 24 | 22 | 24 | 24 | 42 | 33 | 19 | 31 | 47 | 51 |
| Current Liabilities | 5 | 13 | 9 | 11 | 11 | 28 | 17 | 2 | 14 | 29 | 32 |
| Non Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 8 | 11 | 13 | 13 | 14 | 15 | 16 | 17 | 17 | 18 | 19 |
| Reserve & Surplus | -8 | -5 | -4 | -3 | -3 | -1 | -0 | 1 | 1 | 2 | 3 |
| Share Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 | 2 | -2 |
| Investing Activities | -0 | -0 | -1 | -0 | -1 | -0 | -0 | -0 | 0 | 0 | -0 |
| Operating Activities | 0 | 0 | 1 | 1 | 1 | 1 | 1 | -0 | -0 | 2 | -2 |
| Financing Activities | 0 | 0 | -0 | 0 | -0 | -1 | -1 | 0 | 0 | -0 | 0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.82 % | 46.79 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.03 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 35.72 % | 37.15 % | 37.62 % | 37.95 % | 37.97 % | 37.84 % | 37.87 % | 38.04 % | 38.13 % | 38.09 % | 37.97 % | 37.67 % | 38.03 % | 37.27 % | 38.02 % | 38.18 % | 38.31 % | 38.18 % | 38.23 % |
| Others | 17.38 % | 15.95 % | 15.48 % | 15.15 % | 15.13 % | 15.27 % | 15.23 % | 15.06 % | 14.97 % | 15.01 % | 15.13 % | 15.43 % | 15.04 % | 15.83 % | 15.08 % | 14.92 % | 14.79 % | 14.92 % | 14.89 % |
| No of Share Holders | 0 | 29,874 | 29,164 | 28,720 | 27,834 | 29,961 | 29,280 | 28,257 | 27,475 | 26,741 | 26,123 | 25,864 | 26,581 | 25,480 | 26,422 | 26,114 | 25,914 | 25,685 | 25,196 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 64.85 | 80.39 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 68.40 | 62.00 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 54.94 | 53.50 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 46.38 | 50.85 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 43.68 | 43.29 |
| 27 Sept 2025 | Annual General Meeting | NA | 27 Sept 2025 | 43.29 | 41.77 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Oct 04, 2025
Oct 04, 2025Closure of Trading WindowSep 29, 2025
Sep 29, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 29, 2025
Sep 29, 2025Scrutinizer Report With Voting ResultSep 29, 2025
Sep 29, 2025Scrutinizer Report With Voting ResultSep 29, 2025
Sep 29, 2025Summary Of Proceedings Of 40Th Annual General Meeting Of The Company Held On Saturday 27Th September 2025 Pursuant To Regulation 30 Read With Para A Of Part A Of Schedule III Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015.Sep 27, 2025
Sep 27, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 15, 2025
Sep 15, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 01, 2025
Sep 01, 2025Information Regarding E-Voting For 40Th Annual General MeetingAug 29, 2025
Aug 29, 2025Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository ParticipantsAug 29, 2025
Aug 29, 2025Reg. 34 (1) Annual Report.Aug 29, 2025
Aug 29, 2025Submission Of Notice Of Convening 40Th AGM Of The Company.Aug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 23, 2025
Aug 23, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Change in Registered Office AddressAug 12, 2025
Aug 12, 2025Un-Audited Financial Results For The Quarter Ended 30Th June 2025Aug 12, 2025
Aug 12, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 12Th August 2025 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirement) Regulations 2015Aug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2025
Aug 12, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotAug 08, 2025
Aug 08, 2025Board Meeting Intimation for Intimation For Meeting Of Board Of Directors Of The Company Schedule To Be Held On Tuesday 12Th August 2025 Pursuant To Regulation 29 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Aug 04, 2025
Aug 04, 2025Continuous Disclosure Under Sub-Para 1 Of Para A Of Part A Of Schedule III Of The SEBI (LODR) Regulations 2015 Read With SEBI Circular SEBI/HO/CFD/CFD-Pod-1/P/CIR/2023/123 Dated 13Th July 2023Aug 04, 2025
Aug 04, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 04Th August 2025 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 04, 2025
Aug 04, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 03, 2025
Jul 03, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Intimation To The Shareholders Holding Shares In Physical Mode For Mandatory Furnishing Of PAN KYC Details Bank Account Details Nomination And Other Details.Jun 12, 2025
Jun 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
May 31, 2025Audited Financial Result For The Financial Year Ended 31.03.2025May 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 30Th May 2025 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Board Meeting Intimation for Intimation For Meeting Of Board Of The Directors (Serial No.02/2025-26) Of The Company Scheduled To Be Held On Friday 30Th May 2025.May 22, 2025
May 22, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 22, 2025
Apr 22, 2025Announcement Under Regulation 30 (5) Of SEBI (LODR) Regulation 2015Apr 19, 2025
Apr 19, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 19, 2025
Apr 19, 2025Appointment of Company Secretary and Compliance OfficerApr 19, 2025
Apr 19, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 05, 2025
Apr 05, 2025Closure of Trading WindowMar 25, 2025
Mar 25, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 22, 2025
Mar 22, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 22, 2025
Mar 22, 2025Announcement under Regulation 30 (LODR)-DemiseMar 11, 2025
Mar 11, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 11, 2025
Mar 11, 2025Revise Calender Of Events For Postal BallotFeb 19, 2025
Feb 19, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 18, 2025
Feb 18, 2025Calender Of Events Of Postal BallotFeb 17, 2025
Feb 17, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Feb 13, 2025Technical Indicators
RSI(14)
Neutral 34.33
ATR(14)
Less Volatile 1.64
STOCH(9,6)
Neutral 22.52
STOCH RSI(14)
Neutral 25.27
MACD(12,26)
Bearish -0.11
ADX(14)
Weak Trend 19.73
UO(9)
Bearish 38.21
ROC(12)
Downtrend And Accelerating -4.63
WillR(14)
Oversold -84.30
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
